TVAX BIOMEDICAL
TVAX Biomedical is a clinical stage development company advancing its targeted cell-based immunotherapy for the treatment of cancer. The company’s proprietary therapeutic approach offers the promise of improved clinical outcomes, low toxicity and the potential for fundamentally changing the way cancer is treated. TVAX Immunotherapy is a unique personalized combination of cancer cell vaccination and “killer” T cell treatment. This treatment has demonstrated the potential to effectivel... y treat numerous cancers without many of the undesirable side effects associated with radiation and chemotherapy. A key distinction between TVAX and other cancer immunotherapy companies is that TVI uses its patented approach to combine both cancer vaccination and activated “killer” T cell treatment. While each of these separate approaches has demonstrated therapeutic potential, neither has demonstrated the efficacy to be a viable standalone treatment.
TVAX BIOMEDICAL
Social Links:
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2004-01-01
Address:
Lenexa, Kansas, United States
Country:
United States
Website Url:
http://www.tvaxbiomedical.com
Total Employee:
1+
Status:
Active
Contact:
(913) 492-2221
Email Addresses:
[email protected]
Total Funding:
14.68 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Analytics Microsoft Exchange Online Google Office 365 Mail Microsoft Azure DNS JQuery CDN
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
DEKK-TEC, Inc.
Novel therapies for the treatment of cancer.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.tvaxbiomedical.com Semrush global rank: 5.79 M Semrush visits lastest month: 1.23 K
- Host name: 26.141.209.35.bc.googleusercontent.com
- IP address: 35.209.141.26
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "TVAX Biomedical"
About – TVAX Biomedical
Wayne O. Carter, D.V.M., Ph.D., TVAX’s Chief Executive Officer joined TVAX Biomedical in 2019 and serves as a member of the Board of Directors.Prior to that, he served as the President …See details»
TVAX Biomedical
TVAX Biomedical is developing an exciting novel approach to cancer treatment (TVAX Immunotherapy ®) that offers the opportunity of improved clinical outcomes for patients with …See details»
TVAX Biomedical - Crunchbase Company Profile
TVAX Biomedical is a clinical stage development company advancing its targeted cell-based immunotherapy for the treatment of cancer. The company’s …See details»
Tvax Biomedical I, LLC - Dun & Bradstreet
Company Description: TVAX may be a clever play on the company's methods but it is completely serious about killing cancer. TVAX Biomedical uses cancer cell vaccination and the …See details»
TVAX Biomedical, Inc. | LinkedIn
TVAX Biomedical, Inc. | 405 followers on LinkedIn. Vaccine-enhanced adoptive T cell immunotherapy ...developing an immune response against one's own tumor. | TVAX …See details»
TVAX Biomedical, Inc. | Lenexa, KS, USA Startup - gust.com
Website tvaxbiomedical.com; Company Summary TVAX Biomedical is advancing a Phase 3-ready brain cancer program. The company's unique therapy combines personalized cancer …See details»
TVAX Biomedical Company Profile - Office Locations, Competitors …
TVAX Biomedical has 5 employees across 2 locations and $13.3 m in total funding,. See insights on TVAX Biomedical including office locations, competitors, revenue, financials, executives, …See details»
Contact Us - TVAX Biomedical
TVAX Biomedical, Inc. PO Box 19311 Lenexa, KS 66285-9311. Phone: 1.913.492.2221 Revolutionizing Cancer Care, One Patient at a TimeSee details»
TVAX Biomedical - PitchBook
TVAX Biomedical General Information Description. Developer of targeted cell-based immunotherapies designed to provide paradigm-shifting cancer treatment. The company's …See details»
TVAX Biomedical LLC - VentureRadar
TVAX is developing alternative personalized cancer therapies. The company states that its technology involves vaccination to induce the immune system... ... Find out ...See details»
TVAX Biomedical, Inc. - Cell-Based Immunotherapy For The …
TVAX Biomedical is a clinical stage development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer. TVAX Biomedical is developing a paradigm …See details»
TVAX Biomedical Company Information - Funding, Investors, and …
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
Capital Health Partnering with TVAX Biomedical to Offer Brain …
Jul 2, 2024 Only Participating Clinical Site in the Northeast United States. Capital Health Cancer Center has announced that it has joined TVAX Biomedical, Inc.’s clinical trial to study a …See details»
CLINICAL DATA – TVAX Biomedical
While the brain cancer therapies represent the company’s most advanced candidates and clinical programs, TVAX also has safety and proof of concept preclinical and human data in breast, …See details»
TVAX Biomedical announces major advancements in potential …
OLATHE, Kan., Dec. 9, 2020 /PRNewswire/ -- TVAX Biomedical (TVAX), is a cancer immunotherapy company that is moving into its pivotal glioblastoma study for FDA regulatory …See details»
TVAX Biomedical Receives Fast Track Designation from the FDA …
OLATHE, Kan., June 4, 2020 /PRNewswire/ -- TVAX Biomedical announced today receipt of Fast Track Designation from the U.S. Food and Drug Administration (FDA) for the use of its vaccine …See details»
THE TVAX IMMUNOTHERAPY® PLATFORM – TVAX Biomedical
Surgery : Surgical removal of the patient’s cancer tissue is required to generate a personalized vaccine.TVAX converts cancer tissue into a large number of individual cancer cells in its …See details»
Capital Health Partnering with TVAX Biomedical to Offer Brain …
Jul 8, 2024 Only Participating Clinical Site in the Northeast United States. HOPEWELL, N.J., July 8, 2024 /PRNewswire/ -- Capital Health Cancer Center has announced that it has joined …See details»
SCIENTIFIC RATIONALE – TVAX Biomedical
TVAX® is working to strengthen the natural ability of the human immune system to strategically attack and eradicate cancer. On its own, the human immune system selectively and …See details»
Soligenix Announces Publication Demonstrating CiVax™ Booster …
5 days ago COVID-19 has been declared a global pandemic by the World Health Organization. The global impact of this emerging infection demonstrates the urgent need for robust …See details»